Article info

Download PDFPDF

Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J’xactly) study

Authors

  1. Correspondence to Dr Yasuo Okumura; okumura.yasuo{at}nihon-u.ac.jp
View Full Text

Citation

Okumura Y, Fukuda I, Nakamura M on behalf of the J’xactly Investigators, et al
Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J’xactly) study

Publication history

  • Received October 25, 2017
  • Revised April 24, 2018
  • Accepted May 15, 2018
  • First published June 22, 2018.
Online issue publication 
June 22, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.